envdna
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2005 (NCT00187148)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- envdna
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00623753 | Phase 1 | May 1, 2007 | St. Jude Children's Hospital |
| NCT00187148 | Phase 1 | Feb 1, 2005 | National Institutes of Health (NIH), St. Jude Children's Hospital |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| St. Jude Children's Hospital | Academic/Hospital | 2 | 2 | 1 | 2005 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2005 |
2 organizations
Page 1 / 1